×
S&P 500   4,158.24
DOW   33,212.96
QQQ   309.10
S&P 500   4,158.24
DOW   33,212.96
QQQ   309.10
S&P 500   4,158.24
DOW   33,212.96
QQQ   309.10
S&P 500   4,158.24
DOW   33,212.96
QQQ   309.10
LON:TLY

Totally (TLY) Share Forecast, Price & News

GBX 40.50
+1.00 (+2.53%)
(As of 05/27/2022 12:00 AM ET)
Add
Compare
Today's Range
39
40.50
50-Day Range
34.09
47.25
52-Week Range
30.05
49.19
Volume
245,654 shs
Average Volume
526,733 shs
Market Capitalization
£75.83 million
P/E Ratio
67.50
Dividend Yield
1.88%
Beta
N/A
30 days | 90 days | 365 days | Advanced Chart
Receive TLY News and Ratings via Email

Sign-up to receive the latest news and ratings for Totally and its competitors with MarketBeat's FREE daily newsletter.

Totally logo

About Totally

Totally plc, through its subsidiaries, provides out-of-hospital healthcare services in the United Kingdom and Ireland. It operates through Urgent Care, Planned Care, and Insourcing segments. The company offers a range of treatment and advice for musculoskeletal injuries and conditions, such as physiotherapy and podiatry to NHS patients; occupational health and ergonomic services to corporate and private clients. It also provides dermatology and referral management services; urgent care services; and clinical health coaching services to educate patients to self-manage their conditions, such as chronic obstructive pulmonary disease; and hospital insourcing services, as well as IT healthcare solutions; and provision for online health and safety risk assessments. The company was incorporated in 1999 and is based in Derby, the United Kingdom.

Headlines

See More Headlines

Industry, Sector and Symbol

Industry
Medical Care
Sub-Industry
N/A
Sector
Medical
CIK
N/A
Fax
N/A
Employees
1,828
Year Founded
N/A

Sales & Book Value

Annual Sales
£121.17 million
Cash Flow
GBX 10.13 per share
Book Value
GBX 19.10 per share

Profitability

Pretax Margin
N/A

Debt

Price-To-Earnings

Miscellaneous

Free Float
N/A
Market Cap
£75.83 million
Optionable
Not Optionable

Company Calendar

Last Earnings
9/29/2017
Today
5/28/2022
Next Earnings (Estimated)
7/04/2022

MarketRank

Overall MarketRank

1.99 out of 5 stars

Analyst Opinion: 3.5Community Rank: 4.8Dividend Strength: 1.7Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -













Totally (LON:TLY) Frequently Asked Questions

Is Totally a buy right now?

1 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Totally in the last twelve months. There are currently 1 buy rating for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" Totally stock.
View analyst ratings for Totally
or view top-rated stocks.

When is Totally's next earnings date?

Totally is scheduled to release its next quarterly earnings announcement on Monday, July 4th 2022.
View our earnings forecast for Totally
.

How were Totally's earnings last quarter?

Totally plc (LON:TLY) posted its quarterly earnings data on Friday, September, 29th. The health services provider reported ($5.00) EPS for the quarter. The health services provider earned $3.68 million during the quarter.
View Totally's earnings history
.

How often does Totally pay dividends? What is the dividend yield for Totally?

Totally declared a dividend on Monday, January 24th. Shareholders of record on Thursday, February 3rd will be given a dividend of GBX 0.50 per share on Friday, February 25th. This represents a dividend yield of 1.46%. The ex-dividend date of this dividend is Thursday, February 3rd. This is a positive change from Totally's previous dividend of GBX 0.25. The official announcement can be seen at this link.
View Totally's dividend history
.

Is Totally a good dividend stock?

Totally pays an annual dividend of GBX 0.01 per share and currently has a dividend yield of 1.88%. The dividend payout ratio of Totally is 0.83%. This payout ratio is at a healthy, sustainable level, below 75%.
View Totally's dividend history.

What price target have analysts set for TLY?

1 Wall Street analysts have issued twelve-month price objectives for Totally's shares. Their forecasts range from GBX 70 to GBX 70. On average, they expect Totally's stock price to reach GBX 70 in the next twelve months. This suggests a possible upside of 72.8% from the stock's current price.
View analysts' price targets for Totally
or view top-rated stocks among Wall Street analysts.

Who are Totally's key executives?
Totally's management team includes the following people:
  • Ms. Wendy Jayne Lawrence, CEO & Exec. Director (Age 60, Pay $281k)
  • Ms. Lisa Barter-Ng A.C.A., Lisa Barter, CFO, Fin. Director & Director (Age 51, Pay $177k)
  • Ms. Gloria Ann Cooke, Clinical Quality Director & Director (Age 69, Pay $132k)
  • Ms. Jayne Storey, Director HR & Recruitment
  • Mr. Richard Benson, Managing Director of Planned Care (Age 54)
  • Mr. Andy Gregory, Managing Director of Urgent Care
  • Ms. Marie Lee, Managing Director of Insourcing
  • Mr. John Charlton, Group Company Sec.
What is Totally's stock symbol?

Totally trades on the London Stock Exchange (LON) under the ticker symbol "TLY."

How do I buy shares of Totally?

Shares of TLY and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.
Compare Top Brokerages Here.

What is Totally's stock price today?

One share of TLY stock can currently be purchased for approximately GBX 40.50.

How much money does Totally make?

Totally has a market capitalization of £75.83 million and generates £121.17 million in revenue each year.

How many employees does Totally have?

Totally employs 1,828 workers across the globe.

What is Totally's official website?

The official website for Totally is www.totallyplc.com.

How can I contact Totally?

Totally's mailing address is Hamilton House, Mabledon Place, LONDON, WC1H 9BB, United Kingdom. The health services provider can be reached via phone at +44-20-38663330.

This page was last updated on 5/28/2022 by MarketBeat.com Staff

Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau MarketBeat is rated as Great on TrustPilot

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.